| Literature DB >> 31412950 |
Mirasbek Kuterbekov1,2,3, Paul Machillot2,3, Francis Baillet4, Alain M Jonas1, Karine Glinel1, Catherine Picart5,6.
Abstract
BACKGROUND: Human adipose-derived stromal cells (hASCs) have been gaining increasing popularity in regenerative medicine thanks to their multipotency, ease of collection, and efficient culture. Similarly to other stromal cells, their function is particularly sensitive to the culture conditions, including the composition of the culture medium. Given the large number of parameters that can play a role in their specification, the rapid assessment would be beneficial to allow the optimization of their culture parameters.Entities:
Keywords: Cell therapy; Design of experiments; Human adipose stromal cell; Osteogenic differentiation
Mesh:
Year: 2019 PMID: 31412950 PMCID: PMC6694725 DOI: 10.1186/s13287-019-1333-7
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Target variables used for the screening of culture parameters for the osteogenic differentiation of hASCs. hASC source and seeding density were chosen as factors related to the stromal cells; base medium, serum, L-ascorbate-2-phosphate, ß-glycerophosphate, dexamethasone, and BMP-9 were chosen as factors related to the medium. The factor variability was set between a certain range based on the values commonly used in literature
| Variable | Description | Range of variability from (-) to (+) | References | ||
|---|---|---|---|---|---|
| V1 | hASC source | ZB | EFS | [ | |
| V2 | Cell seeding density, per well | 2000 | 6000 | 10000 | [ |
| V3 | Base culture medium | DMEM/F-12 | DMEM | [ | |
| V4 | Serum source | 5% hPL | 10% FBS | [ | |
| V5 | L-ascorbate-2-phosphate | 0 | 50 μM | [ | |
| V6 | ß-glycerophosphate | 0 | 10 mM | [ | |
| V7 | Dexamethasone | 0 | 100 nM | [ | |
| V8 | Bone morphogenetic protein-9 | 0 | 100 ng/mL | [ | |
The parameters used to generate the experimental table. In total, 16 conditions were investigated to screen culture parameters for their effect on osteogenic differentiation. hASC human adipose-derived stromal cell, AP l-ascorbate-2-phospate, ßGP ß-glycerophosphate, DEX dexamethasone, BMP-9 bone morphogenetic protein-9. +,− refer to the four added positive and negative controls
| Condition | hASC source | Seeding density (cells/well) | Medium compositions for osteogenic differentiation | |||||
|---|---|---|---|---|---|---|---|---|
| Base medium | Serum | AP (μM) | ßGP (mM) | DEX (nM) | BMP-9 (ng/mL) | |||
| 1 | EFS | 10,000 | DMEM/F-12 | hPL | 50 | 10 | 0 | 0 |
| 2 | ZB | 10,000 | DMEM | FBS | 50 | 10 | 100 | 0 |
| 3 | EFS | 2000 | DMEM | hPL | 0 | 10 | 100 | 100 |
| 4 | ZB | 10,000 | DMEM/F-12 | hPL | 50 | 0 | 100 | 100 |
| 5 | ZB | 2000 | DMEM | FBS | 0 | 10 | 0 | 100 |
| 6 | ZB | 2000 | DMEM/F-12 | hPL | 0 | 10 | 100 | 0 |
| 7 | EFS | 2000 | DMEM/F-12 | FBS | 50 | 0 | 100 | 100 |
| 8 | EFS | 10,000 | DMEM/F-12 | FBS | 0 | 10 | 0 | 100 |
| 9 | EFS | 10,000 | DMEM | FBS | 0 | 0 | 100 | 0 |
| 10 | ZB | 10,000 | DMEM | hPL | 0 | 0 | 0 | 100 |
| 11 | EFS | 2000 | DMEM | hPL | 50 | 0 | 0 | 0 |
| 12 | ZB | 2000 | DMEM/F-12 | FBS | 0 | 0 | 0 | 0 |
| 13− | ZB | 6000 | DMEM | FBS | 0 | 0 | 0 | 0 |
| 14+ | ZB | 6000 | DMEM | FBS | 50 | 10 | 100 | 100 |
| 15− | EFS | 6000 | DMEM | FBS | 0 | 0 | 0 | 0 |
| 16+ | EFS | 6000 | DMEM | FBS | 50 | 10 | 100 | 100 |
Fig. 1Pre-screening of the effect of the sera used during hASC expansion on the validity of controls in the subsequent osteogenic differentiation. hASC-EFS were expanded in either FBS- (blue) or hPL-based (orange) GM, followed by their differentiation in respective OM. For differentiation, both the expectations for the ALP staining and the actual staining results are shown. The latter are representative of 1 biological with 2 technical replicates for each condition. “*” denotes partial or complete cell layer detachment
Fig. 2Results of the ALP staining and its quantification for all the conditions of the DOE analysis. a One of the three 96-well microplates after the ALP staining, displaying all 16 different DOE conditions with 3 technical replicates each. b Quantification of the ALP staining per condition per biological replicate (R1, R2, and R3) using absorbance detection. Results are expressed as means ± standard deviations of the 3 technical replicates
Fig. 3Calculated percent contributions of the variables toward the ALP expression. The variables had either a net positive or a net negative contribution to the ALP expression. If the (+) variability of the variable resulted in higher ALP expression, the contribution was positive; if it led to lower ALP expression, the contribution was deemed negative. The average experimental error between the three biological replicates (4.1%) was used as the significance limit, which resulted in the following ranking of the variables in terms of their final contribution: (1) BMP-9, (2) serum, (3) hASC source, (4) AP, (5) DEX, and (6) seeding density